[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Oncology Adjuvants Market Report 2017

August 2017 | 102 pages | ID: U438EE752E4EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Oncology Adjuvants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Oncology Adjuvants in these regions, from 2012 to 2022 (forecast).
United States Oncology Adjuvants market competition by top manufacturers/players, with Oncology Adjuvants sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Amgen
  • Sanofi
  • Pfizer
  • Eli Lilly
  • BMS
  • AstraZeneca
  • Biogen
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Chemotherapy
  • Hormone Therapy
  • Immunotherapy
  • Targeted Therapy
  • Radiotherapy
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Oncology Adjuvants for each application, including
  • Breast Cancer
  • Glioblastoma
  • Lung Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Sarcoma
  • Prostate Cancer
  • Others
United States Oncology Adjuvants Market Report 2017

1 ONCOLOGY ADJUVANTS OVERVIEW

1.1 Product Overview and Scope of Oncology Adjuvants
1.2 Classification of Oncology Adjuvants by Product Category
  1.2.1 United States Oncology Adjuvants Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Oncology Adjuvants Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Chemotherapy
  1.2.4 Hormone Therapy
  1.2.5 Immunotherapy
  1.2.6 Targeted Therapy
  1.2.7 Radiotherapy
  1.2.8 Others
1.3 United States Oncology Adjuvants Market by Application/End Users
  1.3.1 United States Oncology Adjuvants Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Breast Cancer
  1.3.3 Glioblastoma
  1.3.4 Lung Cancer
  1.3.5 Colorectal Cancer
  1.3.6 Ovarian Cancer
  1.3.7 Sarcoma
  1.3.8 Prostate Cancer
  1.3.9 Others
1.4 United States Oncology Adjuvants Market by Region
  1.4.1 United States Oncology Adjuvants Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Oncology Adjuvants Status and Prospect (2012-2022)
  1.4.3 Southwest Oncology Adjuvants Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Oncology Adjuvants Status and Prospect (2012-2022)
  1.4.5 New England Oncology Adjuvants Status and Prospect (2012-2022)
  1.4.6 The South Oncology Adjuvants Status and Prospect (2012-2022)
  1.4.7 The Midwest Oncology Adjuvants Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Oncology Adjuvants (2012-2022)
  1.5.1 United States Oncology Adjuvants Sales and Growth Rate (2012-2022)
  1.5.2 United States Oncology Adjuvants Revenue and Growth Rate (2012-2022)

2 UNITED STATES ONCOLOGY ADJUVANTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Oncology Adjuvants Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Oncology Adjuvants Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Oncology Adjuvants Average Price by Players/Suppliers (2012-2017)
2.4 United States Oncology Adjuvants Market Competitive Situation and Trends
  2.4.1 United States Oncology Adjuvants Market Concentration Rate
  2.4.2 United States Oncology Adjuvants Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Oncology Adjuvants Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ONCOLOGY ADJUVANTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Oncology Adjuvants Sales and Market Share by Region (2012-2017)
3.2 United States Oncology Adjuvants Revenue and Market Share by Region (2012-2017)
3.3 United States Oncology Adjuvants Price by Region (2012-2017)

4 UNITED STATES ONCOLOGY ADJUVANTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Oncology Adjuvants Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Oncology Adjuvants Revenue and Market Share by Type (2012-2017)
4.3 United States Oncology Adjuvants Price by Type (2012-2017)
4.4 United States Oncology Adjuvants Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ONCOLOGY ADJUVANTS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Oncology Adjuvants Sales and Market Share by Application (2012-2017)
5.2 United States Oncology Adjuvants Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ONCOLOGY ADJUVANTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oncology Adjuvants Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi
  6.2.2 Oncology Adjuvants Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Oncology Adjuvants Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly
  6.4.2 Oncology Adjuvants Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 BMS
  6.5.2 Oncology Adjuvants Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 BMS Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AstraZeneca
  6.6.2 Oncology Adjuvants Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AstraZeneca Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Biogen
  6.7.2 Oncology Adjuvants Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Biogen Oncology Adjuvants Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ONCOLOGY ADJUVANTS MANUFACTURING COST ANALYSIS

7.1 Oncology Adjuvants Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oncology Adjuvants

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oncology Adjuvants Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oncology Adjuvants Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ONCOLOGY ADJUVANTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Oncology Adjuvants Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Oncology Adjuvants Sales Volume Forecast by Type (2017-2022)
11.3 United States Oncology Adjuvants Sales Volume Forecast by Application (2017-2022)
11.4 United States Oncology Adjuvants Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Oncology Adjuvants
Figure United States Oncology Adjuvants Market Size (K Units) by Type (2012-2022)
Figure United States Oncology Adjuvants Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemotherapy Product Picture
Figure Hormone Therapy Product Picture
Figure Immunotherapy Product Picture
Figure Targeted Therapy Product Picture
Figure Radiotherapy Product Picture
Figure Others Product Picture
Figure United States Oncology Adjuvants Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Oncology Adjuvants by Application in 2016
Figure Breast Cancer Examples
Figure Glioblastoma Examples
Figure Lung Cancer Examples
Figure Colorectal Cancer Examples
Figure Ovarian Cancer Examples
Figure Sarcoma Examples
Figure Prostate Cancer Examples
Figure Others Examples
Figure United States Oncology Adjuvants Market Size (Million USD) by Region (2012-2022)
Figure The West Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oncology Adjuvants Sales (K Units) and Growth Rate (2012-2022)
Figure United States Oncology Adjuvants Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Oncology Adjuvants Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Oncology Adjuvants Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Oncology Adjuvants Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oncology Adjuvants Sales Share by Players/Suppliers
Figure 2017 United States Oncology Adjuvants Sales Share by Players/Suppliers
Figure United States Oncology Adjuvants Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Oncology Adjuvants Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Oncology Adjuvants Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Oncology Adjuvants Revenue Share by Players/Suppliers
Figure 2017 United States Oncology Adjuvants Revenue Share by Players/Suppliers
Table United States Market Oncology Adjuvants Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Oncology Adjuvants Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Oncology Adjuvants Market Share of Top 3 Players/Suppliers
Figure United States Oncology Adjuvants Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Oncology Adjuvants Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Oncology Adjuvants Product Category
Table United States Oncology Adjuvants Sales (K Units) by Region (2012-2017)
Table United States Oncology Adjuvants Sales Share by Region (2012-2017)
Figure United States Oncology Adjuvants Sales Share by Region (2012-2017)
Figure United States Oncology Adjuvants Sales Market Share by Region in 2016
Table United States Oncology Adjuvants Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Oncology Adjuvants Revenue Share by Region (2012-2017)
Figure United States Oncology Adjuvants Revenue Market Share by Region (2012-2017)
Figure United States Oncology Adjuvants Revenue Market Share by Region in 2016
Table United States Oncology Adjuvants Price (USD/Unit) by Region (2012-2017)
Table United States Oncology Adjuvants Sales (K Units) by Type (2012-2017)
Table United States Oncology Adjuvants Sales Share by Type (2012-2017)
Figure United States Oncology Adjuvants Sales Share by Type (2012-2017)
Figure United States Oncology Adjuvants Sales Market Share by Type in 2016
Table United States Oncology Adjuvants Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Oncology Adjuvants Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oncology Adjuvants by Type (2012-2017)
Figure Revenue Market Share of Oncology Adjuvants by Type in 2016
Table United States Oncology Adjuvants Price (USD/Unit) by Types (2012-2017)
Figure United States Oncology Adjuvants Sales Growth Rate by Type (2012-2017)
Table United States Oncology Adjuvants Sales (K Units) by Application (2012-2017)
Table United States Oncology Adjuvants Sales Market Share by Application (2012-2017)
Figure United States Oncology Adjuvants Sales Market Share by Application (2012-2017)
Figure United States Oncology Adjuvants Sales Market Share by Application in 2016
Table United States Oncology Adjuvants Sales Growth Rate by Application (2012-2017)
Figure United States Oncology Adjuvants Sales Growth Rate by Application (2012-2017)
Table Amgen Basic Information List
Table Amgen Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Oncology Adjuvants Sales Growth Rate (2012-2017)
Figure Amgen Oncology Adjuvants Sales Market Share in United States (2012-2017)
Figure Amgen Oncology Adjuvants Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Oncology Adjuvants Sales Growth Rate (2012-2017)
Figure Sanofi Oncology Adjuvants Sales Market Share in United States (2012-2017)
Figure Sanofi Oncology Adjuvants Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Oncology Adjuvants Sales Growth Rate (2012-2017)
Figure Pfizer Oncology Adjuvants Sales Market Share in United States (2012-2017)
Figure Pfizer Oncology Adjuvants Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Oncology Adjuvants Sales Growth Rate (2012-2017)
Figure Eli Lilly Oncology Adjuvants Sales Market Share in United States (2012-2017)
Figure Eli Lilly Oncology Adjuvants Revenue Market Share in United States (2012-2017)
Table BMS Basic Information List
Table BMS Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BMS Oncology Adjuvants Sales Growth Rate (2012-2017)
Figure BMS Oncology Adjuvants Sales Market Share in United States (2012-2017)
Figure BMS Oncology Adjuvants Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Oncology Adjuvants Sales Growth Rate (2012-2017)
Figure AstraZeneca Oncology Adjuvants Sales Market Share in United States (2012-2017)
Figure AstraZeneca Oncology Adjuvants Revenue Market Share in United States (2012-2017)
Table Biogen Basic Information List
Table Biogen Oncology Adjuvants Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Oncology Adjuvants Sales Growth Rate (2012-2017)
Figure Biogen Oncology Adjuvants Sales Market Share in United States (2012-2017)
Figure Biogen Oncology Adjuvants Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Adjuvants
Figure Manufacturing Process Analysis of Oncology Adjuvants
Figure Oncology Adjuvants Industrial Chain Analysis
Table Raw Materials Sources of Oncology Adjuvants Major Players/Suppliers in 2016
Table Major Buyers of Oncology Adjuvants
Table Distributors/Traders List
Figure United States Oncology Adjuvants Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Oncology Adjuvants Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Oncology Adjuvants Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Oncology Adjuvants Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Oncology Adjuvants Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Oncology Adjuvants Sales Volume (K Units) Forecast by Type in 2022
Table United States Oncology Adjuvants Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Oncology Adjuvants Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Oncology Adjuvants Sales Volume (K Units) Forecast by Application in 2022
Table United States Oncology Adjuvants Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Oncology Adjuvants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oncology Adjuvants Sales Volume Share Forecast by Region (2017-2022)
Figure United States Oncology Adjuvants Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories